A novel antituberculosis agent exhibits potent clinical efficacy and good safety profile: an open-label, randomized-controlled, multicenter, phase 2a trial
Year: 2025
Type: article
Language: en
Topic: Tuberculosis Research and Epidemiology
Authors and affiliations:
raw_author_name: Naihui Chu
raw_affiliation_strings: Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China. chunaihui1994@sina.com
raw_author_name: Wenjuan Nie
raw_affiliation_strings: Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China
raw_author_name: Juan Du
raw_affiliation_strings: Wuhan Pulmonary Hospital (Wuhan Institute for Tuberculosis Control), Wuhan, Hubei, China
raw_author_name: Manni Wang
raw_affiliation_strings: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China
raw_author_name: Liping Ma
raw_affiliation_strings: Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China
raw_author_name: Qingfeng Wang
raw_affiliation_strings: Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China
raw_author_name: Jun Wang
raw_affiliation_strings: Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China
raw_author_name: Xiaomeng Hu
raw_affiliation_strings: Wuhan Pulmonary Hospital (Wuhan Institute for Tuberculosis Control), Wuhan, Hubei, China
raw_author_name: Jin Wu
raw_affiliation_strings: Wuhan Pulmonary Hospital (Wuhan Institute for Tuberculosis Control), Wuhan, Hubei, China
raw_author_name: Yu Lu
raw_affiliation_strings: Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China
raw_author_name: Mailing Huang
raw_affiliation_strings: Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China
raw_author_name: Yuquan Wei
raw_affiliation_strings: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China
Jumbo Drug Bank Co., Ltd, Chengdu, China
raw_author_name: Zhenling Wang
raw_affiliation_strings: Wuhan Pulmonary Hospital (Wuhan Institute for Tuberculosis Control), Wuhan, Hubei, China. wangzhenling@scu.edu.cn
raw_author_name: Jian-Qing He
raw_affiliation_strings: Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, China. jianqing_he@scu.edu.cn
raw_author_name: Zhenyu Ding
raw_affiliation_strings: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China. dingzhenyu@scu.edu.cn
raw_author_name: Xiawei Wei
raw_affiliation_strings: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China. xiaweiwei@scu.edu.cn
Jumbo Drug Bank Co., Ltd, Chengdu, China. xiaweiwei@scu.edu.cn